Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 51

    1.

    Diversity of human leukemia xenograft mouse models: implications for disease biology.

    Meyer LH, Debatin KM.

    Cancer Res. 2011 Dec 1;71(23):7141-4. Epub 2011 Nov 16. Review.

    PMID:
    22088964
    [PubMed - indexed for MEDLINE]
    2.

    Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling.

    Patterson AD, Maurhofer O, Beyoglu D, Lanz C, Krausz KW, Pabst T, Gonzalez FJ, Dufour JF, Idle JR.

    Cancer Res. 2011 Nov 1;71(21):6590-600. Epub 2011 Sep 7.

    PMID:
    21900402
    [PubMed - indexed for MEDLINE]
    3.

    Bcl-2 family genetic profiling reveals microenvironment-specific determinants of chemotherapeutic response.

    Pritchard JR, Gilbert LA, Meacham CE, Ricks JL, Jiang H, Lauffenburger DA, Hemann MT.

    Cancer Res. 2011 Sep 1;71(17):5850-8. Epub 2011 Jul 22.

    PMID:
    21784872
    [PubMed - indexed for MEDLINE]
    4.

    A novel tumor antigen derived from enhanced degradation of bax protein in human cancers.

    Nunes CT, Miners KL, Dolton G, Pepper C, Fegan C, Mason MD, Man S.

    Cancer Res. 2011 Aug 15;71(16):5435-44. Epub 2011 Jun 22.

    PMID:
    21697278
    [PubMed - indexed for MEDLINE]
    5.

    MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis.

    Gocek E, Wang X, Liu X, Liu CG, Studzinski GP.

    Cancer Res. 2011 Oct 1;71(19):6230-9. Epub 2011 Aug 4.

    PMID:
    21816906
    [PubMed - indexed for MEDLINE]
    6.

    Effect of ON 01910.Na, an anticancer mitotic inhibitor, on cell-cycle progression correlates with RanGAP1 hyperphosphorylation.

    Oussenko IA, Holland JF, Reddy EP, Ohnuma T.

    Cancer Res. 2011 Jul 15;71(14):4968-76. Epub 2011 Jun 6. Erratum in: Cancer Res. 2011 Sep 15;71(18):6086.

    PMID:
    21646468
    [PubMed - indexed for MEDLINE]
    7.

    Human tumor cells killed by anthracyclines induce a tumor-specific immune response.

    Fucikova J, Kralikova P, Fialova A, Brtnicky T, Rob L, Bartunkova J, Spísek R.

    Cancer Res. 2011 Jul 15;71(14):4821-33. Epub 2011 May 20.

    PMID:
    21602432
    [PubMed - indexed for MEDLINE]
    8.

    Stromal niche cells protect early leukemic FLT3-ITD+ progenitor cells against first-generation FLT3 tyrosine kinase inhibitors.

    Parmar A, Marz S, Rushton S, Holzwarth C, Lind K, Kayser S, Döhner K, Peschel C, Oostendorp RA, Götze KS.

    Cancer Res. 2011 Jul 1;71(13):4696-706. Epub 2011 May 5.

    PMID:
    21546568
    [PubMed - indexed for MEDLINE]
    9.

    Imatinib sensitivity in BCR-ABL1-positive chronic myeloid leukemia cells is regulated by the remaining normal ABL1 allele.

    Virgili A, Koptyra M, Dasgupta Y, Glodkowska-Mrowka E, Stoklosa T, Nacheva EP, Skorski T.

    Cancer Res. 2011 Aug 15;71(16):5381-6. Epub 2011 Jun 21.

    PMID:
    21693657
    [PubMed - indexed for MEDLINE]
    10.

    Common and overlapping oncogenic pathways contribute to the evolution of acute myeloid leukemias.

    Kvinlaug BT, Chan WI, Bullinger L, Ramaswami M, Sears C, Foster D, Lazic SE, Okabe R, Benner A, Lee BH, De Silva I, Valk PJ, Delwel R, Armstrong SA, Döhner H, Gilliland DG, Huntly BJ.

    Cancer Res. 2011 Jun 15;71(12):4117-29. Epub 2011 Apr 19.

    PMID:
    21505102
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.

    PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation.

    Norde WJ, Maas F, Hobo W, Korman A, Quigley M, Kester MG, Hebeda K, Falkenburg JH, Schaap N, de Witte TM, van der Voort R, Dolstra H.

    Cancer Res. 2011 Aug 1;71(15):5111-22. Epub 2011 Jun 9.

    PMID:
    21659460
    [PubMed - indexed for MEDLINE]
    12.

    IL-7 contributes to the progression of human T-cell acute lymphoblastic leukemias.

    Silva A, Laranjeira AB, Martins LR, Cardoso BA, Demengeot J, Yunes JA, Seddon B, Barata JT.

    Cancer Res. 2011 Jul 15;71(14):4780-9. Epub 2011 May 18.

    PMID:
    21593192
    [PubMed - indexed for MEDLINE]
    13.

    Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network.

    Audrito V, Vaisitti T, Rossi D, Gottardi D, D'Arena G, Laurenti L, Gaidano G, Malavasi F, Deaglio S.

    Cancer Res. 2011 Jul 1;71(13):4473-83. Epub 2011 May 12.

    PMID:
    21565980
    [PubMed - indexed for MEDLINE]
    14.

    The ABL switch control inhibitor DCC-2036 is active against the chronic myeloid leukemia mutant BCR-ABLT315I and exhibits a narrow resistance profile.

    Eide CA, Adrian LT, Tyner JW, Mac Partlin M, Anderson DJ, Wise SC, Smith BD, Petillo PA, Flynn DL, Deininger MW, O'Hare T, Druker BJ.

    Cancer Res. 2011 May 1;71(9):3189-95. Epub 2011 Apr 19.

    PMID:
    21505103
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    PDK1 attenuation fails to prevent tumor formation in PTEN-deficient transgenic mouse models.

    Ellwood-Yen K, Keilhack H, Kunii K, Dolinski B, Connor Y, Hu K, Nagashima K, O'Hare E, Erkul Y, Di Bacco A, Gargano D, Shomer NH, Angagaw M, Leccese E, Andrade P, Hurd M, Shin MK, Vogt TF, Northrup A, Bobkova EV, Kasibhatla S, Bronson RT, Scott ML, Draetta G, Richon V, Kohl N, Blume-Jensen P, Andersen JN, Kraus M.

    Cancer Res. 2011 Apr 15;71(8):3052-65.

    PMID:
    21493594
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    A multicellular basis for the origination of blast crisis in chronic myeloid leukemia.

    Sachs RK, Johnsson K, Hahnfeldt P, Luo J, Chen A, Hlatky L.

    Cancer Res. 2011 Apr 15;71(8):2838-47. Epub 2011 Apr 12.

    PMID:
    21487044
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    IRF8 regulates acid ceramidase expression to mediate apoptosis and suppresses myelogeneous leukemia.

    Hu X, Yang D, Zimmerman M, Liu F, Yang J, Kannan S, Burchert A, Szulc Z, Bielawska A, Ozato K, Bhalla K, Liu K.

    Cancer Res. 2011 Apr 15;71(8):2882-91. Epub 2011 Apr 12.

    PMID:
    21487040
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemia.

    Ter Elst A, Ma B, Scherpen FJ, de Jonge HJ, Douwes J, Wierenga AT, Schuringa JJ, Kamps WA, de Bont ES.

    Cancer Res. 2011 Apr 1;71(7):2761-71. Epub 2011 Mar 29.

    PMID:
    21447743
    [PubMed - indexed for MEDLINE]
    Free Article
    19.

    Absence of class II-associated invariant chain peptide on leukemic blasts of patients promotes activation of autologous leukemia-reactive CD4+ T cells.

    van Luijn MM, van den Ancker W, Chamuleau ME, Zevenbergen A, Westers TM, Ossenkoppele GJ, van Ham SM, van de Loosdrecht AA.

    Cancer Res. 2011 Apr 1;71(7):2507-17. Epub 2011 Feb 10.

    PMID:
    21310823
    [PubMed - indexed for MEDLINE]
    Free Article
    20.

    Nm23-h1 indirectly promotes the survival of acute myeloid leukemia blast cells by binding to more mature components of the leukemic clone.

    Lilly AJ, Khanim FL, Hayden RE, Luong QT, Drayson MT, Bunce CM.

    Cancer Res. 2011 Feb 1;71(3):1177-86. Epub 2010 Dec 17.

    PMID:
    21169412
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk